Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph P Gira

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 19, 2024
Migraine is a risk factor for pseudophakic positive dysphotopsia following monofocal lens implantationMaggie J Xing, Thiago A Moulin, Tara Suresh, et al.
Patient Preference and Adherence|March 24, 2017
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative surveyJoseph P Gira, Reginald Sampson, Steven M Silverstein, et al.
Journal of Cataract and Refractive Surgery|October 28, 2018
Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgerySyd L Tyson, Shamik Bafna, Joseph P Gira, et al.
Journal of Cataract and Refractive Surgery|April 6, 2019
ReplySyd L Tyson, Shamik Bafna, Joseph P Gira, et al.
Current Opinion in Ophthalmology|January 19, 2017
Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatmentMark S Milner, Kenneth A Beckman, Jodi I Luchs, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 19, 2024
Migraine is a risk factor for pseudophakic positive dysphotopsia following monofocal lens implantationMaggie J Xing, Thiago A Moulin, Tara Suresh, et al.
Patient Preference and Adherence|March 24, 2017
Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (Dextenza™): results of a qualitative surveyJoseph P Gira, Reginald Sampson, Steven M Silverstein, et al.
Journal of Cataract and Refractive Surgery|October 28, 2018
Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgerySyd L Tyson, Shamik Bafna, Joseph P Gira, et al.
Journal of Cataract and Refractive Surgery|April 6, 2019
ReplySyd L Tyson, Shamik Bafna, Joseph P Gira, et al.
Current Opinion in Ophthalmology|January 19, 2017
Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatmentMark S Milner, Kenneth A Beckman, Jodi I Luchs, et al.
Pageof 1